185 related articles for article (PubMed ID: 22688161)
21. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
22. Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and tumor expression of metalloproteases and their inhibitors in invasive breast cancer.
Cuadriello EF; Fernández-Guinea Ó; Eiró N; González LO; Junquera S; Vizoso FJ
Magn Reson Imaging; 2016 Oct; 34(8):1107-13. PubMed ID: 27114340
[TBL] [Abstract][Full Text] [Related]
23. Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.
Dhakal HP; Bassarova A; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Giercksky KE; Nesland JM
Histol Histopathol; 2009 Aug; 24(8):1049-59. PubMed ID: 19554512
[TBL] [Abstract][Full Text] [Related]
24. The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells.
Nakopoulou L; Giannopoulou I; Lazaris ACh; Alexandrou P; Tsirmpa I; Markaki S; Panayotopoulou E; Keramopoulos A
APMIS; 2003 Nov; 111(11):1027-36. PubMed ID: 14629269
[TBL] [Abstract][Full Text] [Related]
25. MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival.
Nakopoulou L; Tsirmpa I; Alexandrou P; Louvrou A; Ampela C; Markaki S; Davaris PS
Breast Cancer Res Treat; 2003 Jan; 77(2):145-55. PubMed ID: 12602913
[TBL] [Abstract][Full Text] [Related]
26. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
27. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
28. Metalloproteinases 1 and 3 as Potential Biomarkers in Breast Cancer Development.
Argote Camacho AX; González Ramírez AR; Pérez Alonso AJ; Rejón García JD; Olivares Urbano MA; Torné Poyatos P; Ríos Arrabal S; Núñez MI
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445715
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic relevance of MMP-11 expression in the stromal fibroblast-like cells adjacent to invasive ductal carcinoma of the breast.
Min KW; Kim DH; Do SI; Pyo JS; Kim K; Chae SW; Sohn JH; Oh YH; Kim HJ; Choi SH; Choi YJ; Park CH
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S433-42. PubMed ID: 23115007
[TBL] [Abstract][Full Text] [Related]
31. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.
Brummer O; Athar S; Riethdorf L; Löning T; Herbst H
Virchows Arch; 1999 Dec; 435(6):566-73. PubMed ID: 10628798
[TBL] [Abstract][Full Text] [Related]
32. A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.
Eiró N; Fernandez-Garcia B; Vázquez J; Del Casar JM; González LO; Vizoso FJ
Oncoimmunology; 2015 Jul; 4(7):e992222. PubMed ID: 26140253
[TBL] [Abstract][Full Text] [Related]
33. Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer.
del Casar JM; Carreño G; González LO; Junquera S; González-Reyes S; González JM; Bongera M; Merino AM; Vizoso FJ
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1049-58. PubMed ID: 20041335
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
Rahko E; Kauppila S; Pääkkö P; Blanco G; Apaja-Sarkkinen M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Jukkola A
Tumour Biol; 2009; 30(5-6):257-64. PubMed ID: 19887890
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast.
Gonzalez LO; Junquera S; del Casar JM; González L; Marín L; González-Reyes S; Andicoechea A; González-Fernández R; González JM; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2010 Jul; 41(7):980-9. PubMed ID: 20236691
[TBL] [Abstract][Full Text] [Related]
37. Relationship between metalloprotease expression in tumour and stromal cells and aggressive behaviour in prostate carcinoma: Simultaneous high-throughput study of multiple metalloproteases and their inhibitors using tissue array analysis of radical prostatectomy samples.
Fernandez-Gomez J; Escaf S; Gonzalez LO; Suarez A; Gonzalez-Reyes S; González J; Miranda O; Vizoso F
Scand J Urol Nephrol; 2011 Apr; 45(3):171-6. PubMed ID: 21244194
[TBL] [Abstract][Full Text] [Related]
38. [The relationship between laminin-receptor and nm23 protein expression and its correlation with interstitial microvascular density and tumor metastasis in breast carcinoma].
Li Y; Kou B; Wu S; Zhang L; Zhu G
Zhonghua Bing Li Xue Za Zhi; 2000 Jun; 29(3):168-71. PubMed ID: 11866905
[TBL] [Abstract][Full Text] [Related]
39. [Effects of ru'ai shuhou recipe on the matrix metalloproteinases and the inhibitive factors in the recurrence and metastasis of HER2 positive breast cancer].
Wu XQ; Shao SJ; Qu WC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov; 32(11):1526-30. PubMed ID: 23359979
[TBL] [Abstract][Full Text] [Related]
40. Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients.
Giannelli G; Erriquez R; Fransvea E; Daniele A; Trerotoli P; Schittulli F; Grano M; Quaranta M; Antonaci S
Int J Cancer; 2004 May; 109(5):782-5. PubMed ID: 14999790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
